Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spruce Biosciences Inc
(NQ:
SPRB
)
0.4647
+0.0002 (+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
148,689
Open
0.4601
Bid (Size)
0.4611 (6)
Ask (Size)
0.4646 (10)
Prev. Close
0.4645
Today's Range
0.4451 - 0.4647
52wk Range
0.4112 - 5.950
Shares Outstanding
40,710,692
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
August 12, 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 12, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Performance
YTD
-84.30%
-84.30%
1 Month
-10.12%
-10.12%
3 Month
-37.30%
-37.30%
6 Month
-91.18%
-91.18%
1 Year
-79.35%
-79.35%
More News
Read More
Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
July 11, 2024
Via
AB Newswire
Spruce Biosciences Recognized as a Bay Area Best Place to Work
June 06, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
June 04, 2024
Via
Benzinga
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
June 04, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
June 03, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
May 23, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
May 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in May Investor Conferences
May 01, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Pfizer Q1 Earnings and Revenues Beat Estimates
May 01, 2024
Via
Talk Markets
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
April 30, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
April 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 21, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
March 14, 2024
Via
Benzinga
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 14, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
US Stocks Higher; Producer Prices Rise 0.6% In February
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
March 14, 2024
Via
InvestorPlace
Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
March 14, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.